Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/VTRS
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Viatris Inc (VTRS) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Viatris (VTRS) trades at $17.09, up 2.77% with bullish technical signals and positive earnings momentum after beating Q2 2026 estimates. The company shows operational strength with $2.3B operating cash flow and improved net cash flow of $612M in 2025, though profitability remains challenged with negative net margins. Recent FDA approval for Gwyn Lo contraceptive patch and strategic divestitures highlight ongoing business optimization.
While Viatris demonstrates cash flow stability and earnings beats, investors face significant headwinds from persistent negative profitability and high debt levels. The mixed analyst sentiment (30.77% buy rating) reflects cautious optimism amid ongoing restructuring, with potential upside dependent on successful execution of growth initiatives in key markets like Greater China.
Read full analysis

Key Stats

  • Market Cap
    $19.46B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $17.86
  • 52W Low
    $9.49
  • Typical Hold Time
    -
  • Enterprise Value
    $31.57B
  • Div Yield
    2.83%
  • Trading Activity
    -
$16.97
52W Low: $9.49
25 Sep 2025
52W High: $17.86
28 Jul 2026

Track Viatris Inc (VTRS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Viatris Inc has traded between a low of $9.49 and a high of $17.86, highlighting its annual price range. Buy and sell Viatris Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Most Recent News

Content is generated by Aura AI

AmeraMex reports Q3 2026 growth with $5M contract and electric equipment expansion.

AmeraMex International, a heavy equipment provider, reported stable revenue and an 80% gross profit increase in Q3 2026. The company secured a $5 million contract for North American dock expansion and became an approved vendor for California's CORE p...

Market News
4 hours ago
Newsfile Corp
Bullish
news icon
AmeraMex reports Q3 2026 growth with $5M contract and electric equipment expansion.

Jefferies keeps buy on Smith & Nephew despite concerns over H2 growth and CFO departure

Jefferies maintains a 'buy' rating on Smith & Nephew with a 1,500p price target despite investor doubts about achieving 5.0%-5.5% organic sales growth in the second half of 2026. The company lowered its full-year sales growth guidance to 4% from 6%, ...

Market News
4 hours ago
Proactive Investors
Neutral
Jefferies keeps buy on Smith & Nephew despite concerns over H2 growth and CFO departure

Adobe shares fall 6.5% after CEO Shantanu Narayen steps down, Anil Chakravarthy named new CEO.

Adobe announced a leadership change with Anil Chakravarthy, currently president of its digital experience business, set to become CEO starting December 1, succeeding longtime CEO Shantanu Narayen. The news caused Adobe's shares to drop 6.5%. David Wa...

Market News
4 hours ago
Proactive Investors
Bearish
news icon
Adobe shares fall 6.5% after CEO Shantanu Narayen steps down, Anil Chakravarthy named new CEO.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $19.46B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $17.86
  • 52W Low
    $9.49
  • Typical Hold Time
    -
  • Enterprise Value
    $31.57B
  • Div Yield
    2.83%
  • Trading Activity
    -
$16.97
52W Low: $9.49
25 Sep 2025
52W High: $17.86
28 Jul 2026

Track Viatris Inc (VTRS) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Viatris Inc has traded between a low of $9.49 and a high of $17.86, highlighting its annual price range. Buy and sell Viatris Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!